by Dan | Aug 21, 2020 | Main
Pick a pharmaceutical or biologic that is approved in the EU or US that does not presently have a REMS Risk Evaluation and Mitigation Strategy.Try to choose one that has had previous safety issues as evidenced by either communications from Regulatory Authorities or...
